Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Praticien-chercheur
7 articles scientifiques publiés — formation continue solide
Délais de RDV courts dans la région
144.2 rhumatos / 100 000 hab. — département bien doté
8 publications sur 5 ans
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
6
6 articles ont été cités au moins 6fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
116
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
15
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
4
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Hôpital Pontchaillou · Centre Hospitalier Universitaire de Rennes
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Molecular mechanisms underlying transformation of large granular lymphocytic leukemia to high-grade T-cell lymphoma
2023ArticleLeukemia
Observational case-control study of small-fiber neuropathies, with regards on smoking and vitamin D deficiency and other possible causes
2023ArticleFrontiers in Medicine
Pruritus and brain tumours: A prospective and descriptive study
2022ArticleSkin Health and Disease
Sensitive Skin Syndrome: A Low-Noise Small-Fiber Neuropathy Related to Environmental Factors?
2022ArticleFrontiers in Pain Research
Pacific-Ciguatoxin-2 and Brevetoxin-1 Induce the Sensitization of Sensory Receptors Mediating Pain and Pruritus in Sensory Neurons
2021ArticleMarine drugs
Calcium Increase and Substance P Release Induced by the Neurotoxin Brevetoxin-1 in Sensory Neurons: Involvement of PAR2 Activation through Both Cathepsin S and Canonical Signaling
2020ArticleCells
Alteration of Pressure-Induced Vasodilation in Aging and Diabetes, a Neuro-Vascular Damage
2019ArticleFrontiers in Physiology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CABINET DU DR MAXIME FOUCHARD
C.H.P ST-GREGOIRE 6 BOULEVARD DE LA BOUTIERE, 35760 ST GREGOIRE
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
European journal of cancer (Oxford, England : 1990) · 2019
Frontiers in pain research (Lausanne, Switzerland) · 2022
Background and ObjectivesPatients frequently complain of mild, transient, unpleasant skin sensations that cannot be diagnosed as common neuropathies. Dermatologists have termed these symptoms “sensitive skin syndrome.” This narrative review was performed for a better knowledge by other specialists.Databases and Data TreatmentPublications on pain in sensitive skin syndrome were obtained from PubMed.ResultsThere is a growing body of data supporting the concept that sensitive skin is a type of small-fiber neuropathy. The arguments are based on clinical data, a decrease in intra-epidermal nerve fiber density, quantitative sensory testing abnormalities and an association with irritable bowel syndrome and sensitive eyes. Sensitive skin is triggered by environmental factors. Sensitive skin is a frequent condition, with a lifetime prevalence of ~50% according to self-reports.ConclusionsMild levels of skin pain or itch are frequently experienced by patients, who rarely report them. There is a need for a better knowledge of sensitive skin because it can be the first level of small-fiber neuropathies.
Frontiers in medicine · 2021
Background: Pruritus is a frequent adverse event during the use of immune checkpoint inhibitors (ICIs), with a frequency estimated to be between 11 and 47%. The underlying causes remain poorly understood.Objectives: The main goal was to search for putative causes of pruritus occurring in patients treated with ICIs for melanomas and cutaneous carcinomas. Other objectives were to assess the association between the occurrence of pruritus and survival and between the occurrence of pruritus and other adverse events.Methods: A monocentric retrospective descriptive study was performed using data for patients treated with ICIs (nivolumab, pembrolizumab, ipilimumab, and cemiplimab) between August 2010 and November 2019.Results: A total of 181 patients were included (mean age: 69 years). Pruritus was reported by 25 patients (13.8%). We were able to determine three subgroups of pruritus causes under ICI use: pruritus directly related to immunotherapy, pruritus indirectly related through other pruritus-inducing side effects and pruritus unrelated to ICIs. In 6/25 patients, no more specific cause of pruritus was found at the onset of pruritus or in their backgrounds, other than ICI use.Limitations: The study has some limitations due to unicentric and retrospective design.Conclusion: Pruritus was found in 25/181 patients in this series; only in 6/25 patients no potential cause other than ICI could be found, and pruritus was not associated with differences in survival.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Skin health and disease · 2023 · Journal Article
Fardel MA, Brenaut E, Guellec D, Etienne M, et al.
Frontiers in medicine · 2022 · Journal Article
Fouchard M, Brenaut E, Genestet S, Ficheux AS, et al.
Dermatitis : contact, atopic, occupational, drug · 2022 · Journal Article
Le Tallec E, Fouchard M, Dinulescu M
Frontiers in pain research (Lausanne, Switzerland) · 2022 · Journal Article
Misery L, Bataille A, Talagas M, Le Gall-Ianotto C, et al.
Frontiers in medicine · 2021 · Journal Article
Salinas N, Nowak E, Etienne M, Legoupil D, et al.
European journal of cancer (Oxford, England : 1990) · 2019 · Case Reports
Fouchard M, Jantzem H, Quere G, Descourt R, et al.
Rheumatology (Oxford, England) · 2025 · Journal Article
Teboul A, Allenbach Y, Tubach F, Belin L, et al.